Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
11.16
+0.02 (0.18%)
At close: Jun 9, 2025, 4:00 PM
11.25
+0.09 (0.81%)
After-hours: Jun 9, 2025, 5:44 PM EDT
Stoke Therapeutics Employees
Stoke Therapeutics had 128 employees as of December 31, 2024. The number of employees increased by 18 or 16.36% compared to the previous year.
Employees
128
Change (1Y)
18
Growth (1Y)
16.36%
Revenue / Employee
$1,491,469
Profits / Employee
$392,750
Market Cap
609.30M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
STOK News
- 11 days ago - Stoke Therapeutics to Present at the Jefferies Global Healthcare Conference - Business Wire
- 27 days ago - Stoke Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates - Business Wire
- 2 months ago - Stoke Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference - Business Wire
- 2 months ago - Stoke Therapeutics Stock Slips as CEO Steps Down - Investopedia
- 2 months ago - Stoke Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates - Business Wire
- 2 months ago - Stoke Therapeutics Announces CEO Transition - Business Wire
- 3 months ago - Stoke Therapeutics to Present at Upcoming Investor Conferences in March - Business Wire
- 3 months ago - Stoke Therapeutics and Biogen in pact for treatment for severe form of childhood epilepsy - Market Watch